ALACT — Acticor Biotech SA Cashflow Statement
0.000.00%
Last trade - 00:00- €7.49m
- €9.48m
Annual cashflow statement for Acticor Biotech SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.05 | -7.65 | -12.6 | -15.9 | -18.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.115 | 0.281 | 1.18 | 0.941 | 2.34 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.16 | 0.491 | -2.41 | 2.75 | 2.55 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.28 | -6.74 | -13.8 | -12.1 | -13 |
| Capital Expenditures | -0.017 | -0.053 | -0.013 | -0.006 | -0.02 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.343 | 0 | 0.001 | -0.06 | -0.026 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.326 | -0.053 | -0.012 | -0.066 | -0.046 |
| Financing Cash Flow Items | — | -0.001 | -0.424 | 1.93 | 0.981 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.64 | 1.5 | 17.5 | 7.42 | 10.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.69 | -5.29 | 3.76 | -4.75 | -2.71 |